VLA2001
Showing 1 - 8 of 8
SARS-CoV-2 Infection Trial in Groningen, Utrecht, Auckland (VLA2001)
Active, not recruiting
- SARS-CoV-2 Infection
- VLA2001
-
Groningen, Netherlands
- +3 more
Jan 17, 2023
COVID-19 Trial in Cali (VLA 2001)
Not yet recruiting
- COVID-19
- VLA 2001
-
Cali, Valle, ColombiaCentro de Estudios en Infectología Pediátrica
Sep 15, 2022
SARS-CoV-2 Virus Infection Trial in New Zealand (VLA2001)
Active, not recruiting
- SARS-CoV-2 Virus Infection
- VLA2001
-
Auckland, Birkenhead, New Zealand
- +7 more
Feb 3, 2022
SARS-CoV-2 Virus Infection Trial in United Kingdom (VLA2001, AZD1222, VLA2001 - adolescent part)
Active, not recruiting
- SARS-CoV-2 Virus Infection
- VLA2001
- +3 more
-
Barnsley, United Kingdom
- +30 more
Oct 17, 2022
Birth Weight, Pregnancy Weight Gain Trial in Padang (Bread and vla dadiah, Bread and vla without dadiah)
Completed
- Birth Weight
- Pregnancy Weight Gain
- Bread and vla dadiah
- Bread and vla without dadiah
-
Padang, West Sumatera, IndonesiaUniversitas Andalas
Feb 4, 2023
Relapsing-remitting Multiple Sclerosis Trial in Lugano (interferon beta-1b, Natalizumab)
Completed
- Relapsing-remitting Multiple Sclerosis
- interferon beta-1b
- Natalizumab
-
Lugano, Ticino, SwitzerlandNeurocenter of Southern Switzerland, Ospedale Civico Lugano
Mar 13, 2014
Expression in Natalizumab Population With Active Control
Completed
- Multiple Sclerosis
-
Salt Lake City, UtahRocky Mountain MS Clinic
Jun 12, 2013
HIV Seropositivity Trial in Medellin (Lovastatin, )
Completed
- HIV Seropositivity
- Lovastatin
- placebo
-
Medellin, Antioquia, ColombiaGroup of Immunovirology, Research Universitary Center, Universit
Sep 30, 2011